New approach for drug susceptibility testing: monitoring the stress response of mycobacteria.
Methods currently used for in vitro drug susceptibility testing are based on the assessment of bacterial growth-related processes. This reliance on cellular reproduction leads to prolonged incubation times, particularly for slowly growing organisms such as mycobacteria. A new rapid phenotypic method for the drug susceptibility testing of mycobacteria is described. The method is based on the detection of the physiological stress developed by susceptible mycobacterial cells in the presence of an antimicrobial compound. The induced stress was quantified by differential monitoring of the dielectric properties of the bacterial suspension, an easily measurable electronic property. The data presented here characterize the stress developed by Mycobacterium tuberculosis cells treated with rifampin (rifampicin), isoniazid, ethambutol, and pyrazinamide. Changes in the dielectric-based profiles of the drug-treated bacteria revealed the respective susceptibilities in near real time, and the susceptibilities were well correlated with conventional susceptibility test data.
Rieder
Ronald J
RJ
BioSense Technologies, Inc., 4 Arrow Drive, Woburn, MA 01801, USA. rieder@biosensetech.com
Zhao
Zhihui
Z
Zavizion
Boris
B
D017097:Electric Impedance; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000254:growth & development; D011718:Pyrazinamide / Q000494:pharmacology; D013312:Stress, Physiological
D011718:Pyrazinamide
J Clin Microbiol. 2002 Jun;40(6):2238-9
12037096
J Clin Microbiol. 1986 Dec;24(6):976-81
3097069
J Med Microbiol. 2002 Jan;51(1):42-49
11800471
Crit Rev Microbiol. 2005;31(2):69-78
15986832
J Clin Microbiol. 2007 Jan;45(1):179-92
17108078
Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74
8843279
Ann N Y Acad Sci. 2007 Oct;1113:105-13
17483210
N Engl J Med. 2007 Feb 15;356(7):656-9
17301295
J Clin Microbiol. 2007 Aug;45(8):2662-8
17537932
Microbiology (Reading). 2009 Apr;155(Pt 4):1093-1102
19332811
FEMS Microbiol Rev. 2007 Nov;31(6):637-56
17883408
BMC Public Health. 2008 Jan 14;8:15
18194573
Mini Rev Med Chem. 2007 Nov;7(11):1177-85
18045221
Ann N Y Acad Sci. 2007 Oct;1113:95-104
17483204
Lancet Infect Dis. 2009 Mar;9(3):153-61
19246019
Eur Respir J Suppl. 2002 Jul;36:87s-94s
12168751
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17025-30
12482953
J Bacteriol. 2006 Nov;188(22):7988-91
16980465
Curr Opin Struct Biol. 2007 Dec;17(6):755-60
17920859
Antimicrob Agents Chemother. 1995 Oct;39(10):2235-8
8619574
Antimicrob Agents Chemother. 2007 Jun;51(6):2100-4
17438054
MMWR Recomm Rep. 2005 Apr 15;54(RR-6):1-12
15829862
J Clin Microbiol. 1996 Jan;34(1):84-6
8748279
Clin Infect Dis. 2002 Nov 1;35(9):1106-12
12384845
J Clin Microbiol. 2000 Oct;38(10):3686-8
11015384